Filter
795
Text search:
vaccine
trial
Featured
Recommendations
91
New Publications
168
Language
Document type
No document type
360
Studies & Reports
152
Guidelines
140
Fact sheets
39
Manuals
38
Strategic & Response Plan
25
Training Material
13
Situation Updates
11
Resource Platforms
10
Videos
4
Brochures
1
App
1
Infographics
1
Countries / Regions
Global
33
India
28
Sierra Leone
18
Kenya
17
South Africa
17
Liberia
13
West and Central Africa
13
Western and Central Europe
13
Uganda
12
Brazil
12
East and Southern Africa
11
Africa
10
Russia
10
Ethiopia
9
Eastern Europe
9
Nigeria
8
Ghana
8
Philippines
7
South Sudan
7
Latin America and the Carribbean
7
Guinea
6
Congo, Democratic Republic of
6
Zimbabwe
6
Zambia
6
Rwanda
6
Nepal
5
Tanzania
5
Bangladesh
5
Middle East and North Africa
5
Germany
4
Malawi
4
Mozambique
4
Ukraine
4
Myanmar / Burma
4
Syria
3
Cambodia
3
Paraguay
3
Asia
3
USA
2
Jordan
2
Lebanon
2
Thailand
2
Indonesia
2
Argentina
2
Namibia
2
Angola
2
Lesotho
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Burkina Faso
1
Guinea-Bissau
1
Cameroon
1
Haiti
1
Pakistan
1
Iraq
1
Turkey
1
Gambia
1
China
1
Papua New Guinea
1
Sudan
1
Honduras
1
Ecuador
1
Botswana
1
Chile
1
Yemen
1
Western Pacific Region
1
Venezuela
1
Southern Africa
1
Laos
1
Vietnam
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
202
Clinical Guidelines
110
Women & Child Health
55
Public Health
37
Key Resources
11
Pharmacy & Technologies
8
Capacity Building
2
Toolboxes
COVID-19
196
TB
73
HIV
64
Ebola
47
Rapid Response
33
NTDs
31
AMR
20
Pharmacy
15
Mental Health
13
Planetary Health
11
Global Health Education
10
NCDs
10
Cholera
9
Health Financing Toolbox
9
Refugee
8
Polio
7
Zika
6
Caregiver
6
Conflict
5
Disability
2
Natural Hazards
1
This bi-weekly brief details the latest developments in scientific knowledge and public health policy from around the world as well as updates to the COVID-19-related guidance from Africa CDC, WHO and other public health agencies.
21 January 2022
The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection, transmission, clinical disease and death; (iii) how virulent the variant is compared to other varian
...
Nature | Vol 600 | 2 December 2021 |
Временное руководство, Первый выпуск 8 января 2021 г., Обновлено 15 июня 2021 г., Обновлено 19 ноября 2021 г.
A rapid evidence briefing. Vaccinated people are less likely to develop long COVID, even if they get infected, a rapid review of 15 studies by the UK Health Security Agency shows.
Tuberculosis (TB)
recommended
MEDBOX Issue Brief no. 19: World TB Day: Invest to end TB. Save Lives
Wearing a face mask can help reduce the spread of COVID-19 in the community by reducing the release of respiratory droplets from asymptomatic / pre-symptomatic individuals or those with mild non-specific symptoms. The use of face masks for this purpose may be adopted to reduce the societal impact as
...
20 April 2022. The response to the COVID-19 pandemic continues to adversely affect essential TB services in many countries. A first report of case studies was published in 2021 comprising 23 examples of innovative interventions implemented by countries to effectively respond to disruptions of TB ser
...
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation was to agree on the most important PPCs for drugs t
...
Report of the WHO/Bill & Melinda Gates Foundation Consultation. The Consultation was organized back-to-back with the first annual meeting of the International Coordinating Group of the BMGF-funded project for human and dog rabies elimination in developing countries, held at WHO headquarters, Geneva,
...
The aim of this toolkit is to guide countries on how to best estimate their current burden of dengue by combining existing data from dengue surveillance systems with on-going research efforts to measure the community burden
of dengue.
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher
...
This project aimed to reduce the risk of vector-borne infection with Chagas disease by
controlling triatomine bugs, the vectors transmitting the parasite of Chagas disease, and
establishing an epidemiological surveillance system with community participation.
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f
...
The conditionality of this recommendation is largely driven by the current higher unit cost of pyrethroid-PBO ITNs compared
to pyrethroid-only LLINs and therefore the uncertainty of their cost-effectiveness. Furthermore, as PBO is less wash-resistant
than pyrethroids, its bioavailability declines
...
Rabies has an enormous impact on both agriculture and conservation biology, but its greatest burden is undeniably on public health. As such, routine methods for rapid risk assessment after human exposures to rabies as well as applications for laboratory-based surveillance, production of biologicals
...
Driving progress towards rabies elimination: Results of Gavi’s Learning Agenda on rabies and new WHO position on rabies immunization
The Pharmaceutical Forum of the Americas (PFA) has previously published guidelines and organised campaigns for community pharmacists on the prevention, detection and control of arbovirus infections in 2018 with a grant from the FIP Foundation for Pharmacy Education and Research. Building on that exp
...
